The stock market has been bullish for years now, and most companies are richly valued as a result. Meanwhile, dividend yields remain low -- right now, the SPDR S&P 500 ETF (NYSEMKT:SPY) offers just 1.7%. What's an investor seeking returns to do? These businesses have the winning trifecta: a stable dividend, ongoing earnings growth, and attractive valuation...
One attractive option is the pharmaceutical sector, where some large-cap companies are maintaining the winning trifecta of a stable dividend yield, ongoing earnings growth, and attractive valuation. For these three businesses in particular, company-specific events including acquisitions and new drugs make for particularly enticing prospects. Let's take a look at AbbVie (NYSE:ABBV), Bristol-Myers Squibb (NYSE:BMY), and Gilead Sciences (NASDAQ:GILD).
Source: Motley Fool
Related Articles:
- If Only I Had Known About These Dividend Stocks...
- 12 Dividend Stocks and 3 ETFs To Balance Your Asset Allocation
- 3 Communications Services Stocks With Increasing Dividends
- 4 Stocks With Room To Grow Their Dividend
- 6 Stocks That Have Paid Dividends For Over 100 Years
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.